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Abstract We have cloned a human CGMPdependent protein 
kinase type II cDNA to examine its gene expression in terms of 
cellular senescence and/or immortalization. The genetic locus was 
mapped to band 4q21 by FISH. Northern blot analysis revealed 
that expression of the type II gene was markedly decreased or 
lost ln mortal or immortal human fibroblasts producing SV40 T 
antigen. Also in various immortalized cell lines tested, the gene 
was not expressed. In normal diploid fibroblasts, the gene was 
constitutively expressed during cell-cycle and population doubling 
lrvels (PDLs). 
Aey words: cGMP-dependent protein kinase; Gene expression; 
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I Introduction 
Recently, we have shown that the inhibitors of cGMP-de- 
pendent protein kinase (cGK) block cellular senescence in- 
cluced by heat inactivation of thermolabile SV40 T antigen in 
immortalized human fibroblast cell lines [l]. It is therefore 
s Jggested that cGK has some relevance to cellular proliferation 
s nce cellular senescence can be taken as one form of growth 
c 3ntrol. 
To date, two types of cGK, type1 which exists as a dimer of 
Llentical subunits and and type II which exists as a monomer, 
f ave been identified in various organisms. The type I is ex- 
pressed as two isomers, a and /I isoforms, which differ from 
each other only in the amino-terminal region where dimeriza- 
tton is thought to occur [2-51. The type I is found predomi- 
I iantly in the cytosol of virtually all cell types, whereas type II 
i\ shown to be membrane-bound and localized primarily to 
tpithelial tissues [6,7].The cDNAs encoding both type Ia and 
1,9 isoforms have been cloned from bovine [8], human [9], 
I )rosophilu [lo], and that encoding the type II has been cloned 
1 ‘-om Drosophila [lo], mouse [l 11, and rat [12]. As regards their 
i ,mctions, only limited roles in specialized biological functions 
Lave been reported [ 11. 
By cloning and characterization of the human type 11 cDNA, 
r’re report the mode of expression of the human cGK genes 
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especially in terms of cellular senescence and/or immortaliza- 
tion 
2. Materials and Methods 
2.1. Cell lines and culture conditions 
Mortal lines SVts 6-l and SVts 9-5, immortal lines SVts 7-I and 
SVts 8, each isolated following transfection of human diploid fibro- 
blasts (TIG3) with plasmid pMT-1 encoding thermolabile SV40 T anti- 
gen, have been described previously [13,14]. Diploid fibroblast line 
WI-38, its SV40-transformed immortal derivative VA13 [15], and the 
other immortal cell lines used were obtained from Japanese Resources 
Cell Bank (National Institute of Health of Japan). The cells were cul- 
tured in Dulbecco’s modified Eagle’s medium supplemented with 10% 
fetal bovine serum at 37°C in plastic Petri dishes except that SVts lines 
were cultured at their permissive temperature of 35°C as described 
[16,17]. 
2.2. RT-PCR amplification 
Poly(A)’ RNA was purified from normal diploid fibrolasts (TlG3) 
using oligo(dT)-latex beads (Takara, Kyoto, Japan) as described [l&19] 
and reverse-transcribed into first strand cDNA in a mixture containing 
50 mM Tris (pH 8.3), 40 mM KCl, 4 mM dithiothreitol, 6 mM MgCl,, 
0.1 mM each dNTP, 50 fig/ml random hexamers, 20 U/ml RNase 
inhibitor (Amersham), 500 ng/20 ~1 poly(A)’ RNA, and 12 units of 
AMV reverse transcriptase (RAV-2, Takara) by incubation at 42°C for 
1 h. An aliquot of the first strand cDNA was used for the following 
PCR amnlification. The reaction mixtures (10 ul) contained 1 ne of first 
strand cDNA, 0.5 PM of each oligonucleoiide drimer, 50 mM ‘ccl, 10 
mM Tris (pH 8.4), bovine serum albumin (10 &ml), 200 PM each 
dNTP, and 0.5 units of Taq DNA polymerase (Promega). The reaction 
profile was denaturation for 1 min at 94”C, annealing for 1 min at 45”C, 
and extension for 3 min at 72°C with 30 rounds of amplification in a 
model 2000 DNA thermal cycler (Perkin Elmer Cetus). 
To amplify a consensus sequence in human cGK II mRNA, two 
degenerate oligonucleotide primers were used in RT-PCRs.The sense 
primer was S-GARYTIGCIATIYTITAYAAYTG-3’ encoding the 
amino acid sequence ELAILYNC, and the antisense primer was 5’- 
CCRCARAAIGTCCAIGTYTT-3’ encoding KTWTFCG (I: inosine; 
R: A or G; Y: C or T). 
2.3. cDNA cloning and sequencing 
PCR products were separated on agarose gels, electroeluted from the 
gel slices, and were directly cloned into T-vector (Invitrogen). The 
resulting plasmids were sequenced by the dideoxynucleotide chain ter- 
mination method with T3 and T7 primers and a modified T7 DNA 
polymerase (Sequenase,USB kit verI1) as described [20]. Several of 
these clones (1.1 kb products) containing a sequence homologous to 
that of mouse brain cGKI1 were used in subsequent analysis. 
To isolate a full-length cDNA clone, the above sequence was labeled 
with [“P]dCTP by random priming and used to screen approximately 
1 x 10” recombinant 1ZapII phage clones containing cDNA prepared 
from TIG3 cells using a cDNA synthesis kit (BRL-choice &stem) as 
described [18,19]. The phage clones were converted to pBluescript in 
vivo and the inserts were subcloned to sequence both strands [20]. 
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2.4. Chromosomal localization by direct R-banding FISH Iate genomic DNA fragments as described [21]. Purified phage DNAs 
The 2.3 kb cDNA fragment encoding human cGKII was ued to were used in the direct R-banding fluorescence in situ hybridization 
screen approximately 2 x IO6 recombinant IDASH phage clones to iso- (FISH) which is based on FISH combined with replicated prometa- 
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Fig. 1. Alignment of the amino acid sequences of four cGKI1 species. The human cGKI1 sequence is compared with mouse brain cGKI1, rat intestinal 
mucosa cGKI1, and the deduced cDNA sequence of the Drosophila DG2 gene. The N-terminal portion of this cDNA is not shown due to very low 
sequence homology. 
M Fujii et al. I FEBS Letters 375 (1995) 263-267 
phase R-banded chromosomes as described previously [22]. The R- 
banded chromosomes were hybridized with biotinylated phage DNA 
in the presence of human Cot-l DNA (BRL) and conjugated with 
fluorescein-labeled avidin. After stained with propidium iodide, micro- 
photographs were taken with filter combinations (Nikon B-2A and 
B 2E) and Provia 100 film (Fuji, IS0 100). 
2 i. Northern blot unalysis 
RNA samples were resolved by electrophoresis on formaldehyde- 
a:. arose gels, transferred onto nylon filters, and hybridized with a “P- 
la Teled cDNA probe in a mixture consisting of 0.43 M Na-P,, 7% SDS, 
1’ b bovine serum albumin and 20 mM EDTA (16 h at 38°C). The filters 
u :re washed twice in 2 x SSC and 0.1% SDS and twice with 0.1 x SSC 
a’ d 0.1% SDS at 65°C for 30 min as described [20]. 
3 Results 
3 1. Cloning and charucterization oj’human cGKII cDNA 
To clone a member of the human cGK family, we performed 
PT-PCR using degenerate primers and cDNA made from 
h .tman fibroblasts. These primers were designed to encode con- 
s’ rved motifs and catalytic domains of Drosophila and mouse 
c,3KII sequences, respectively [lo,1 11. PCR products revealed 
t JO major DNA bands of 1 .O kb and 1.1 kb in size on agarose 
g :l electrophoresis [l 11. Upon cloning and sequencing of more 
t ran 10 clones derived from these two bands, the 1 .O kb DNA 
bind was found to result from human type I cGK sequence [9] 
a rd the 1.1 kb band was highly homologous to the type II cGK 
s :quence of mouse brain [l 11. No other sequence was detected 
f om the above clones. Using one 1.1 kb clone as a probe, we 
s :reened a cDNA library constructed from normal diploid fi- 
t roblasts, and isolated two overlapping cDNA clones of 2.3 kb 
a Id 1 .O kb in size, which represent the full-length human ho- 
rtolog of the mouse cGK11 cDNA. 
The nucleotide sequence of the above two clones revealed an 
( pen reading frame of 2,286 bp with the first ATG surrounded 
1 y an appropriate Kozak consensus sequence [23]. The pre- 
c icted open reading frame encodes a protein of 762 amino acid 
r :sidues (87 kDa). The deduced amino acid sequence showed 
t te characteristic domains of the known cGKI1 proteins [9-l 11; 
i e. a tandemly duplicated cGMP-binding domain (aa 148409) 
f allowed by a typical protein kinase domain (aa 45&714) 
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(Fig. 1). The human cGKI1 was compared to other known 
cGKI1. The amino acid sequence was 95.9% and 95.7% homol- 
ogous to those of rat intestinal mucosa 1121 and mouse brain 
[l 11, respectively (Fig. 1). The nucleotide sequence was 96.0% 
and 96.5% homologous to those of mouse and rat species, 
respectively. 
3.2. Genetic locus of’ the human cGKII gene 
To localize the human cGKI1 gene on human chromosomes, 
we screened a human genomic library and isolated five inde- 
pendent phage clones which were confirmed to contain a frag- 
ment of the cGKI1 gene by exon mapping followed by partial 
sequencing. 
We examined 100 typical R-banded (pro)metaphase spreads 
for each 1 phage clone. In one case, 28% exhibited complete 
twin spots on both homologs, 51% were incomplete single and/ 
or twin spots on either or both homologs, and no spots were 
detected in the others (21%). All of the five genomic clones gave 
similar results. The signals were localized to band q21.1-q21.3 
on chromosome 4. The gene could therefore be assigned to the 
band 4q21.1-q21.3 (Fig. 2). 
3.3. Genr expression during cell cycle und population doubling 
levels 
We examined expression of the cGKI1 gene during cell cycle 
in normal diploid fibroblastsTIG3 cells were synchronized in 
G,, phase of the cell cycle by serum starvation and induced to 
proliferate by addition of 10% serum [20]. We monitored a 6.0 
kb major species of the cGKI1 mRNA by Northern blot anal- 
ysis using the 2.3 kb cDNA as a probe.The mRNA level in- 
creased slightly (2-fold) during cell cycle progression from G,, 
to S phase (Fig. 3A). 
Then, we examined the mRNA level in WI-38 cells at their 
late PDL and a senescent state in culture. In the senesced cells, 
the mRNA level was increased by 2- to 3-fold (Fig. 3B). In 
senesced TIG3 cells, however, the mRNA levels was not signif- 
icantly increased (not shown). 
3.4. Gene expression in various cell lines 
We examined the cGKI1 mRNA levels in various cell lines 
I ‘ig. 2. Whole R-banded metaphase plate (a: B-2A, b: B-2E) after FISH with the human cGKI1 gene as a probe. Arrows indicate the signals on 
4q21.1-q21.3. 
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by Northern blot analysis. In three normal diploid fibroblast 
lines TIGl, TIG3 and WI-38, their levels were similar (Fig. 4). 
In contrast, SVts 61 (mortal), SVts 9-5 (mortal), SVts 771 
(immortal) and SVts 8 (immortal), all derived from TIG3 cells 
following transfection with a plasmid encoding SV40 large T 
antigen, showed a marked decrease in their mRNA levels (Fig. 
4). The mRNA was also undetectable in WI-38 VA13 (Fig. 4), 
an immortal SV40-transformed derivative of WI-38, and two 
SV40-transformed immortal lines, W-V and PSV8 11, both de- 
rived from the fibroblasts of patients with Werner’s syndrome 
(not shown). The loss of expression of the type II gene was 
confirmed by the more sensitive method of RT-PCR (not 
shown). In this assay, the cGKI1 transcript was not detected 
in the immortal lines SVts 7-l and SVts 8 and a trace amount 
was detected in the mortal lines SVts 6-l and SVts 9-5. These 
results show that the expression of the cGKI1 gene is abolished 
upon introduction of SV40 T antigen regardless of whether cells 
are mortal or immortal. 
We then examined the cGKI1 mRNA level in other types of 
immoral lines (not shown). Two immortalized lines KMST-6 
and SUSM- 1, established in vitro from diploid fibroblasts fol- 
lowing repeated y-irradiation and treatment with 4-nitro-qui- 
noline l-oxide, respectively, and shown to be free of DNA 
tumor viruses [16], did not express the cGKI1 gene. Also, 
tumor-derived immortal cell lines tested [19,20] such as HT1080 
(fibrosarcoma), HeLa (cervical tumor), SAOS-2 (osteosar- 
coma), HL60 (promyelocytic leukemia) or Y79 (retinoblas- 
toma) did not express the gene. 
A 
Time after stimulation ( h ) 
0 4 12 24 48 
GAF'DH- 
B 
P s 
GAPDH- 
Fig. 3. Northern blot analysis of cGKI1 mRNA during cell cycle (A) 
and between PDLs (B). In (A) TIG3 cells (40 PDL) were synchronized 
in the resting phase by serum starvation and stimulated to proliferate 
by addition of 10% serum. The cells were then harvested to prepare 
mRNA samples at intervals as indicated. In (B) WI-38 cells at a late 
PDL (P: proliferating) and at a senescent state (S: senescence) were 
harvested to examine the cGKI1 mRNA.The cells obtained from the 
Cell Bank at the above PDL enter senescence with additional 21 PDLs. 
The same blots (2 pg mRNA) were hybridized with the radio-labeled 
1.1 kb cGKI1 cDNA and glyceraldehyde monophosphate dehydorge- 
nase (GAPDH) cDNA as probes. 
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SV40 T antigen 
- _ + t + + - +I 
TIG TIG SVts SVts SVts SVts WI VA 
1 3 6-l 9-5 7-l 8 38 13 
cGK II + 
GAPDH+ 
Fig. 4. Northern blot analysis of cGKI1 mRNA in various cell lines, 
The same blots (2,~g mRNA) were hybridized as described in the legent 
to Fig. 3. The samples are indicated above the lanes. Producers and 
nonproducers of SV40 T antigen are marked with + and -, respectively. 
4. Discussion 
We have cloned the human cGKI1 cDNA to examine expres- 
sion of both type I and type II genes in terms of cellular senes- 
cence and/or immortalization. By phylogenetic analysis, the 
human cGKI1 cDNA described here is most closely related to 
the recently cloned counterparts of mouse brain [l l] and rat 
intestinal [12]. The genetic locus of the type I gene (4q21.1- 
q21.3) is distinct from that of the type Ib gene (lOqll.2) [25]. 
In normal diploid fibroblasts, expression of the cGKI1 gene 
seemed to be slightly increased during cell cycle and in senesced 
cells. However, such changes were not large enough to draw 
any biological significance. In contrast, the expression of the 
type II gene varied significantly among cell types. Most remark- 
ably, the expression was abolished in the cell lines expressing 
SV40 T antigen regardless of whether they were mortal or 
immortal whereas that of the type I cGK gene did not change 
significantly. Also in non-tumorigenic immortalized fibroblast 
lines and several tumor-derived immortalized cell lines tested, 
the expression was not detected. Therefore, the expression of 
the cGKI1 gene seems to be restricted to normal types of cells 
and to be abolished by introduction of SV40 T antigen or 
immortalization. 
The above results led to suggest that the type11 gene may be 
regulated by p53 and/or pRB because their functions are inac- 
tivated by SV40 T antigen and frequently lost in tumor-derived 
cell lines. Therefore, we examined the effect of p53 on expres- 
sion of the cGKI1 gene using SAOS-2 cells (~53~/pRB-) trans- 
fected with a plasmid encoding temperature-sensitive human 
p53 [24]. However, the cGKI1 mRNA was not increased to a 
detectable level at the permissive temperature where mdm2 and 
p21 (waf/cipl/sdil) mRNAs were substantially induced [24]. 
At present, the biological roles of type I and type II cGK are 
unknown. Since mortal and immortal types of fibroblasts pro- 
ducing T antigen failed to express the cGKI1 gene, the loss of 
its expression is not a specific trait of immortal cells. However, 
type II cGK might be inhibitory to rapidly proliferating cells 
since its transcript was so far detected only in normal types of 
cells. 
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